These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32090117)

  • 21. Impact of reinforcement of diabetes self-care on poorly controlled diabetes: a randomized controlled trial.
    Beverly EA; Fitzgerald SM; Brooks KM; Hultgren BA; Ganda OP; Munshi M; Weinger K
    Diabetes Educ; 2013; 39(4):504-14. PubMed ID: 23640303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Tailored Cognitive-Behavioural Intervention Produces Comparable Reductions in Regimen-Related Distress in Adults With Type 2 Diabetes Regardless of Insulin Use: 12-Month Outcomes From the COMRADE Trial.
    Lutes LD; Cummings DM; Littlewood K; Le MT; Kirian K; Patil S; Solar C; Carraway M; Hambidge B
    Can J Diabetes; 2020 Aug; 44(6):530-536. PubMed ID: 32792107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study.
    Shan S; Gu L; Lou Q; Ouyang X; Yu Y; Wu H; Bian R
    Clin Exp Med; 2017 Feb; 17(1):79-84. PubMed ID: 26695015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose.
    Su JB; Wang XQ; Chen JF; Wu G; Jin Y
    Chin Med J (Engl); 2011 Jan; 124(1):144-7. PubMed ID: 21362322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes.
    Koga M; Murai J; Saito H; Kasayama S
    Diabetes Care; 2010 Feb; 33(2):270-2. PubMed ID: 19846794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions, and weight.
    Karl D; Philis-Tsimikas A; Darsow T; Lorenzi G; Kellmeyer T; Lutz K; Wang Y; Frias JP
    Diabetes Technol Ther; 2007 Apr; 9(2):191-9. PubMed ID: 17425446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health Coaching Reduces HbA1c in Type 2 Diabetic Patients From a Lower-Socioeconomic Status Community: A Randomized Controlled Trial.
    Wayne N; Perez DF; Kaplan DM; Ritvo P
    J Med Internet Res; 2015 Oct; 17(10):e224. PubMed ID: 26441467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
    Rosenstock J; Sugimoto D; Strange P; Stewart JA; Soltes-Rak E; Dailey G
    Diabetes Care; 2006 Mar; 29(3):554-9. PubMed ID: 16505505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A
    Tian J; Ohkuma T; Cooper M; Harrap S; Mancia G; Poulter N; Wang JG; Zoungas S; Woodward M; Chalmers J
    Diabetes Care; 2020 Jun; 43(6):1293-1299. PubMed ID: 32193249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial.
    Pilmark NS; Lyngbæk M; Oberholzer L; Elkjær I; Petersen-Bønding C; Kofoed K; Siebenmann C; Kellenberger K; van Hall G; Abildgaard J; Ellingsgaard H; Lauridsen C; Ried-Larsen M; Pedersen BK; Hansen KB; Karstoft K
    Diabetologia; 2021 Feb; 64(2):397-409. PubMed ID: 32979074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A whey/guar "preload" improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12-week, single-blind, randomized, placebo-controlled trial.
    Watson LE; Phillips LK; Wu T; Bound MJ; Checklin HL; Grivell J; Jones KL; Clifton PM; Horowitz M; Rayner CK
    Diabetes Obes Metab; 2019 Apr; 21(4):930-938. PubMed ID: 30520216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
    Fonseca VA; Rosenstock J; Wang AC; Truitt KE; Jones MR
    Diabetes Care; 2008 Aug; 31(8):1479-84. PubMed ID: 18458145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial.
    McInnes N; Smith A; Otto R; Vandermey J; Punthakee Z; Sherifali D; Balasubramanian K; Hall S; Gerstein HC
    J Clin Endocrinol Metab; 2017 May; 102(5):1596-1605. PubMed ID: 28324049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial.
    DeFronzo RA; Bergenstal RM; Cefalu WT; Pullman J; Lerman S; Bode BW; Phillips LS;
    Diabetes Care; 2005 Aug; 28(8):1922-8. PubMed ID: 16043733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effect of the Internet-based glucose monitoring system on HbA1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care system.
    Cho JH; Chang SA; Kwon HS; Choi YH; Ko SH; Moon SD; Yoo SJ; Song KH; Son HS; Kim HS; Lee WC; Cha BY; Son HY; Yoon KH
    Diabetes Care; 2006 Dec; 29(12):2625-31. PubMed ID: 17130195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial.
    Li X; Cai X; Ma X; Jing L; Gu J; Bao L; Li J; Xu M; Zhang Z; Li Y
    Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes.
    Rosenstock J; Rigby SP; Ford DM; Tao B; Chou HS
    Horm Metab Res; 2014 May; 46(5):348-53. PubMed ID: 24356792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of twice-daily biphasic insulin aspart 70/30 and once-daily insulin glargine in persons with type 2 diabetes mellitus inadequately controlled on basal insulin and oral therapy: a randomized, open-label study.
    Ligthelm RJ; Gylvin T; DeLuzio T; Raskin P
    Endocr Pract; 2011; 17(1):41-50. PubMed ID: 20713345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
    J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.